Tag archive for ‘Valeant’
Jewish Business News On Saturday, January 2nd, 2016

Tax savings make Bill Ackman cut his firm’s stake in Valeant

    Citing tax reasons, Bill Ackman, the activist investor and a strong defender of Valeant Pharmaceuticals International, has reduced his firm’s stake in the drug company. In a regulatory filing, More...

News Brief On Tuesday, December 8th, 2015

Reuters Exclusive: Valeant considers selling contact lens maker Paragon – sources

Valeant Pharmaceuticals is reaching out to potential buyers for its specialty contact lens manufacturing division, Paragon Vision Sciences, amid scrutiny from the Federal Trade Commission, according to More...

News Brief On Friday, November 13th, 2015

Valeant, Ackman must face U.S. insider trading lawsuit

  A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before More...

News On Thursday, November 12th, 2015

Bill Ackman Defends Pershing Square’s Losses in Valeant Investment

  From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse off as a result of Valeant’s strategy. Still, Valeant More...

Jewish Business News On Sunday, November 8th, 2015

Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says

  Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman Sachs to secure loans made to chairman and More...

Eli Horn On Monday, January 26th, 2015

Bill Ackman Joins Ranks of Most Successful Hedge Fund Managers

Besides climbing to the top of the hedge fund world, activist investor Bill Ackman has become one of the most successful hedge fund managers of all time after his Pershing Square made huge profits from big bets More...

Vered Weiss On Wednesday, January 7th, 2015

Alpha Wolf Bill Ackman Is Top Dog on Wall Street

Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the previous year for his pressure to put Ron Johnson of AppleStores as More...

Vered Weiss On Tuesday, December 30th, 2014

Is Bill Ackman Guilty of Insider Trading?

Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker Allergan, although for many months, he was pushing the company to accept More...

Reuters On Tuesday, December 9th, 2014

Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making More...

Tibi Singer On Wednesday, November 26th, 2014

Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D

The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...

Wordpress site Developed by Fixing WordPress Problems